Active lesson count:227

118844    2019-2020 Influenza Season: A Review for Pharmacists and Pharmacy Technicians
118843    2019-2020 Influenza Season: A Review for Pharmacists and Pharmacy Technicians
118837    USP General Chapter <797> 2019 Update: A Guide to Sterile Compounding for Pharmacy Personnel
118836    USP General Chapter <797> 2019 Update: A Guide to Sterile Compounding for Pharmacy Personnel
118820    Smoking Cessation Counseling by Pharmacists: Taking It to the Next Level: Podcast 4 - Benefits and Barriers in Pharmacy-Based Smoking Cessation Programs (Part 4 of a 4-Podcast Series)
118819    Smoking Cessation Counseling by Pharmacists: Taking It to the Next Level: Podcast 3 - Pharmacologic Smoking Cessation: Picking the Best Agent for the Patient (Part 3 of a 4-Podcast Series)
118818    Smoking Cessation Counseling by Pharmacists: Taking It to the Next Level: Podcast 2 - Vaping: A Smoking Cessation Tool—Or New Way to be Hooked on Nicotine? (Part 2 of a 4-Podcast Series)
118817    Smoking Cessation Counseling by Pharmacists: Taking It to the Next Level: Podcast 1 - Using Motivational Interviewing in Smoking Cessation Counseling (Part 1 of a 4-Podcast Series)
118821    Module 1. Anatomical and Physiological Considerations for Drug Therapy in Non-Human Species
118816    The Drug Supply Chain Security Act (DSCSA): Improving Integrity Through Track and Trace
118815    The Drug Supply Chain Security Act (DSCSA): Improving Integrity Through Track and Trace
118814    Module 1. Anatomical and Physiological Considerations for Drug Therapy in Non-Human Species
118813    Cannabidiol: A Moving Target for Regulators and Health Care Practitioners
118812    Cannabidiol: A Moving Target for Regulators and Health Care Practitioners
118721    Exploring the Connection of Gene Therapy and Spinal Muscular Atrophy (Podcast)
118658    Updates in the Treatment of Influenza: What Pharmacists Need to Know
118734    New Guidelines and Strategies to Manage CVD Residual Risk: Beyond Statin Therapy
118628    The Pursuit of Hepatitis C Elimination: How the Pharmacist Can Make a Difference Part 2: Understanding the Landscape of Current HCV Treatment
118681    Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in the ICU
118680    LGBTQ+ Cultural Awareness and Best Practices Continuing Education for Pharmacists and Pharmacy Technicians
118679    LGBTQ+ Cultural Awareness and Best Practices Continuing Education for Pharmacists and Pharmacy Technicians
118678    The Pharmacist’s and Pharmacy Technician’s Role in Addressing Human Trafficking
118677    The Pharmacist’s and Pharmacy Technician’s Role in Addressing Human Trafficking
118594    IDH Inhibitors in the Management of Acute Myeloid Leukemia: Focus on Safety and Efficacy
118646    HIV/HCV Coinfection: Treatment Overview and Considerations for Antiretroviral and Direct Acting Antiviral Use
118644    Augmenting Pain Therapy with Self-Massage
118627    The Pursuit of Hepatitis C Elimination: How the Pharmacist Can Make a Difference Part 1: The Pharmacists’ Role in HCV Testing and Counseling—Reaching Patients With the Greatest Need
118641    Immunizations in Special Populations
118563    Incorporating Immunotherapy in the Treatment of Hepatocellular Carcinoma: New Horizons for Improving Outcomes
118593    Pharmacy Laws and Regulations in Texas: Recent Updates to the Texas Pharmacy Act and the Texas Board of Pharmacy Rules
118584    The Role of Continuous Glucose Monitoring in Pharmacy Practice
118582    Pharmacy Laws and Regulations in Texas: Recent Updates to the Texas Pharmacy Act and the Texas Board of Pharmacy Rules
118564    Type 2 Inflammation in Asthma: New Understandings and New Treatment Options
118536    Type 2 Inflammation in Asthma: New Understandings and New Treatment Options
118551    New Horizons in ALS: What Specialty Pharmacists Need to Know
118549    Pharmacists’ Role in the Comprehensive Care of Acute Coronary Syndrome
118527    Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
118518    Selecting and Compounding Medications for Ophthalmic Use
118517    Selecting and Compounding Medications for Ophthalmic Use
118516    Emergency Contraception: An Update for Pharmacists
118515    Module 5, Part 2. Communication With Physicians and Other Healthcare Providers
118514    Module 5, Part 1. Communication Essentials: Tips for Patient and Care Giver Communication
118513    Module 4. Developing a Medication Action Plan for MTM
118512    Module 3. Collection and Evaluation of Patient-specific Information
118511    Module 1. Overview and Definition of Medication Therapy Management (MTM)
118507    Module 2. Identifying Patients for MTM Services
118506    Module 15. Medication Safety and Error Prevention
118505    Module 14. Assessing and Optimizing Patient Adherence in MTM
118504    Module 13. Bone and Joint Diseases
118502    Module 12. Psychiatric Disorders
118501    Module 11: Urological Disorders
118500    Module 10. Gastrointestinal Disorders
118499    Module 9. Respiratory Diseases
118488    Module 8: Cardiovascular Disease
118485    Module 7. Endocrine Disorders
118483    Module 6. Practicing Evidence-Based Medicine
118475    Oncology Consults: The Latest on the Biosimilar Revolution
118469    Opioid Analgesics: Risk Evaluation and Mitigation Strategy (REMS)
118468    Assessing Antibiotic Pharmacology and Susceptibility to Guide Selection and Improve Outcomes
118457    Updates in the Management of ALS for Clinical Pharmacy Specialists: Treatment (Part 2 of a 2-part Podcast Series)
118456    Updates in the Management of ALS for Clinical Pharmacy Specialists: Recognition and Diagnosis (Part 1 of a 2-part Podcast Series)
118467    Module 10: A Review of Nonsterile Compounding Essentials for Veterinary Patients
118466    A Review of Nonsterile Compounding Essentials for Veterinary Patients
118441    Changing the Treatment Landscape: Embracing Long-Acting Injectable Antipsychotics
118358    A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm
118357    Transforming the Treatment Paradigm in B-Cell Malignancies: Pharmacist Insights into BTK Inhibitors
118397    New Evidence to Improve Management of Patients with or at High Risk of ASCVD Events
118394    Evidence-Based Treatment of Hypercholesterolemia: Patient-Centered Evaluation and Management
118380    Module 5: Understanding Insulin Therapy for Pharmacy Technicians
118388    The Pharmacist’s Role in Managing Disease-Modifying Therapies in Adults With Multiple Sclerosis
118360    The Immune Checkpoint Inhibitor Landscape: Patient Management in Renal Cell Carcinoma (Part 2)
118359    The Immune Checkpoint Inhibitor Landscape: Treatment Decision Making in Renal Cell Carcinoma (Part 1)
118381    Update on GLP-1 Receptor Agonists and SGLT2 Inhibitors
118307    Anticoagulant Selection in Atrial Fibrillation: Understanding the Implications of Real-World Evidence
118352    Safe and Responsible Disposal of Medication: Why it’s Important
118308    Optimizing Use of Biologic DMARDs in Rheumatoid Arthritis
118238    Module 7. Exercise for Better Health: Physical Activity Recommendations in Diabetes
118230    Module 10. Troubleshooting Glucose Fluctuations: Impact of Concomitant Medications on Glycemic Control
118229    Module 9. Overview of Diabetes Complications and Common Comorbidities
118228    Module 13: Analyzing Health Care Quality and Cost: An Overview of MTM Star Ratings
118227    Module 8. Insulin Pumps and Continuous Glucose Monitors (CGMs) for Diabetes Management
118205    Module 3. Overview of Non-Insulin Injectable Glucose-Lowering Agents
118203    Module 8. Diabetes and Nutrition 101
118201    Module 6: Understanding Insulin Therapy
118198    Module 2. Diabetes and Nutrition 101
118197    MODULE 7. Blood Glucose Monitoring
118194    Module 11: Diabetes Control in the Hospital Setting: What Pharmacists Need to Know
118165    Module 4. Overview of Non-Injectable Glucose-Lowering Agents
118164    Module 3. Exercise for Better Health: Physical Activity Recommendations in Diabetes
118160    Module 5. Overview of Non-Insulin Injectable Glucose-Lowering Agents
118159    Module 1. Diabetes Defined: An Overview of Prevalence and Pathophysiology
118152    Module 12: ADA and AADE Diabetes Programs in the Community Pharmacy Setting: Basic Concepts for Pharmacists
118240    Targeted Nutrition Delivery in Critically Ill Patients: Focus on Protein Needs and Delivery
118191    New Concepts in Patient Blood Management: How Hospital-Based Pharmacists Can Manage Anemia and Reduce Transfusion Rates
118166    Addressing Rising Anemia Rates in Women: What Can Pharmacists Do to Improve Detection and Management?
118150    Diabetes Update: New Agents and New Treatment Approaches
118074    The Immune Checkpoint Inhibitor Landscape: Where We Are in 2019
118155    Insomnia 101: Dreaming of a Good Night’s Sleep
118149    Insomnia 101: Dreaming of a Good Night’s Sleep
118132    Employing Immuno-Oncology Biomarkers to Guide Treatment Decision- Making: Managed Care and Specialty Pharmacist Perspectives
118131    MEDICAL MARIJUANA: PHARMACOLOGIC CONSIDERATIONS AND REGULATORY UPDATE
118130    MEDICAL MARIJUANA: PHARMACOLOGIC CONSIDERATIONS AND REGULATORY UPDATE
118034    Counseling Patients about Smoking Cessation in the New Era of Cigarette Alternatives
117722    Counseling Patients about Smoking Cessation in the New Era of Cigarette Alternatives
117721    Counseling Patients about Smoking Cessation in the New Era of Cigarette Alternatives
117699    Type 1 Gaucher Disease: Optimizing Treatment and Management Approaches
117725    Safe and Responsible Disposal of Medication: Why it’s Important
117683    Improving Recognition and Outcomes of Osteoarthritis of the Knee: Pharmacists as Key Contributors to the Cause
117695    Latest Developments in the Management of Atrial Fibrillation
117685    Module 9. The Role of the Pharmacy Technician in Medication Therapy Management Services and the Importance of the Complete Medication Review
117680    Module 6. Staying Alert for Insulin Safety: Promoting Safe Practices to Protect Patients
117720    Turning the Tide on Venous Thromboembolism Applying Anticoagulation Best Practices to Reduce the Disease Burden
117669    Incorporating Cancer Immunotherapies Into the Oncology Treatment Arsenal in Managed Care Settings: Navigating the Complexities of Value Assessment & Cost Optimization in the Era of Immuno-Oncology
117661    Interprofessional Team Management of Multidrug-Resistant Gram-Negative Bacterial Infections
117652    Module 2. Identifying Oral Agents Used to Treat Diabetes
117648    2018 Update: The Utility of Root Cause Analysis and Failure Mode and Effects Analysis in the Hospital Setting
117590    2018 Update: The Utility of Root Cause Analysis and Failure Mode and Effects Analysis in the Hospital Setting
117647    Medication Safety in Patients with Diabetes
117646    Medication Safety in Patients with Diabetes
117560    Biomarkers in Immunotherapy Treatment Decision Making: Advancing Personalized Medicine in Oncology (Podcast)
117614    Reducing Glycemic Variability in Type 1 Diabetes: An Exploration of Non-Insulin Treatment Options
117616    Primer on Prevention and Treatment of HIV Infection
117561    Examining Real World Evidence in the Management of Breast Cancer: Pharmacist Implications
117568    Identification and Management of Atopic Dermatitis-Applying Advances to Improve Outcomes: Treatment and Emerging Therapies in Moderate-to-Severe Atopic Dermatitis
117559    Biomarkers in Immunotherapy Treatment Decision Making; Advancing Personalized Medicine in Oncology
117555    Bringing Focus to Psoriatic Arthritis: Real-World Cases of Patient Needs and Pharmacist Interventions
117558    Improving Outcomes in Patients With Renal Transplants: Identifying, Monitoring, and Increasing Adherence
117557    Individualizing Treatment in Women with Chronic Heart Failure
117556    Bringing Focus to Psoriatic Arthritis: Real-World Cases of Patient Needs and Pharmacist Interventions
117417    New Advances in Improving Adherence and Reducing Motor Fluctuations among Patients with Parkinson’s Disease
117567    Identification and Management of Atopic Dermatitis: Applying Advances to Improve Outcomes: Treatment and Emerging Therapies in Moderate-to-Severe Atopic Dermatitis
117562    The Future of Alzheimer’s Disease Treatment: Implications for Managed Care Pharmacists
117545    Cannabinoids in Epilepsy: New Horizons for Improving the Management of Severe Seizure Disorders
117501    Examining Real World Evidence in the Management of Breast Cancer: Pharmacist Implications
117502    Anticoagulation in the Cancer Patient: Pharmacist Perspectives on the Management of Venous Thromboembolism
117543    Pain Management Principles and Pharmacology
117527    Biosimilars in Oncology: Current Status, Future Directions, and Clinical Considerations
117526    Naloxone and Other Harm-Reduction Strategies for Opioid Use Disorder
117521    Naloxone and Other Harm-Reduction Strategies for Opioid Use Disorder
117520    Identification and Stabilization of Patients with Opioid Use Disorder
117518    Identification and Stabilization of Patients with Opioid Use Disorder
117488    Pulmonary Arterial Hypertension Management in the Inpatient Setting: Focus on Pharmacotherapy
117454    The Drug Supply Chain Security Act: Improving the Integrity of Drug Distribution—2018 Update
117452    The Drug Supply Chain Security Act: Improving the Integrity of Drug Distribution—2018 Update
117515    Individualizing Treatment in Women with Chronic Heart Failure
117400    Oncology Pharmacy Consults: Evolving Therapies for Advanced or Metastatic Breast Cancer: A Focus on CDK 4/6 Inhibition
117459    Updates on Non-flu Vaccines/Delivering Series Vaccines in the Pharmacy Setting
117445    Updates on Non-flu Vaccines/Delivering Series Vaccines in the Pharmacy Setting
117376    Paradigm Shifts in Migraine Treatment: Implications for Pharmacists
117398    Biosimilars in the Era of Value-Based Care: Pharmacist-Driven Strategies for Implementing Patient-Centered Management
117397    Improving Adherence to Long Acting Injectable Antipsychotic Therapy: Rationale for Pharmacist Involvement
117386    Evolving Therapies for Advanced or Metastatic Hormone Receptor Positive (HR+) Breast Cancer: Pharmacist Interventions That Improve CDK4/6 Inhibitor Therapy Outcomes – Case 2
117385    Evolving Therapies for Advanced or Metastatic Hormone Receptor Positive (HR+) Breast Cancer: How Safety Profiles of CDK4/6 Inhibitors Affect Choice of First-Line Therapy – Case 1
117381    Vaccination Needs in the Older Adult: The Pharmacist’s Role
117368    Medication Assisted Treatment in Patients with Opioid Use Disorder
117366    Medication Assisted Treatment in Patients with Opioid Use Disorder
117367    Regulatory and Ethical Issues in Veterinary Pharmacy
117350    Managing Pain in Older Adults
117349    Managing Pain in Older Adults
117342    Update on the Drug Overdose Crisis: More Than Prescription Opioids
117340    Update on the Drug Overdose Crisis: More Than Prescription Opioids
117283    2018-2019 Influenza Season: A Review for Pharmacists and Pharmacy Technicians
117279    2018-2019 Influenza Season: A Review for Pharmacists and Pharmacy Technicians
117277    Evidence-Based Management of Chronic Hyperkalemia: A Case-Based Approach
117339    DEA Enforcement Actions
117288    DEA Enforcement Actions
117160    The Role of the Pharmacist in Managing Patients with X-Linked Hypophosphatemia
117053    The Aging HIV Patient: Sharpening Skills, Grasping Guidelines (Article)
116986    Reversal of Direct Oral Anticoagulants: Patient Management and Clinical Considerations
116294    HIV/AIDS: A Review for Pharmacy Technicians
116234    Questions, Questions, Question: Influenza Takes the Nation by Storm
116233    Questions, Questions, Question: Influenza Takes the Nation by Storm
116231    Beyond Fiber and Laxatives: Advising Patients with Chronic and Refractory Constipation-Article
116227    Extending the Pharmacist’s Knowledge: Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients
116171    How Specialty Pharmacists Can Enhance Patient-Driven Care in Multiple Sclerosis
115974    Immunoglobulin G: A Primary Strategy in Secondary Immunodeficiency
115973    Chronic Idiopathic Constipation: Incorporating Newer Agents Into Evidence-Based Care
115972    Chronic Hyperkalemia: Evolving Options for a Common Problem
115971    Management of Short Bowel Syndrome: The Pharmacist’s Perspective
115965    Individualizing Long-Acting Contraceptive Choices: A Guide for Patient Counseling
115954    What’s New for Fluoroquinolones in the Treatment of Acute Bacterial Skin and Skin Structure Infections?
115940    Expanding the Pharmacist’s Role in Preventing Opioid Abuse: Understanding Abuse-deterrent Formulations and Identifying Risks
115930    Improving the Impact of the Specialty Pharmacist in the Care of Patients with Acquired Hemophilia A
115920    Anticoagulant-related Bleeding: An Update for Pharmacists
115910    Understanding the Mechanisms of DMARD Therapy and MTM Strategies in Rheumatoid Arthritis
115783    2017 Update: Module 11. Arranging for Reimbursement of MTM Services
115782    2017 Update: Module 10. Controlled Substances and Risk Evaluation Mitigation Strategies (REMS)
115781    2017 Update: Module 9. Generic Drugs and Therapeutic Equivalence
115780    2017 Update: Module 8. Medication Use Among Older Adults
115779    2017 Update: Module 7. Polypharmacy and MTM
115778    2017 Update: Module 6. The Importance of Chronic Disease Management in MTM
115777    2017 Update: Module 5. Helping Patients with Drug Benefits and Coverage
115775    2017 Update: Module 4. How Can Technicians Help to Maximize Medication Safety?
115773    2017 Update: Module 3. Medication Reconciliation—Steps for the Pharmacy Technician
115772    2017 Update: Module 2. Medication Therapy Management Procedures and Documents
115771    2017 Update: Module 1. Introduction to Medication Therapy Management (MTM)
115830    Providing Relief to Patients with Atopic Dermatitis: How Pharmacists Can Help - Article
115751    2017-2018 Influenza Season: A Review for Pharmacists and Pharmacy Technicians
115750    2017-2018 Influenza Season: A Review for Pharmacists and Pharmacy Technicians
115747    Improving Pneumococcal Vaccine Utilization in Long Term Care Facilities
115571    Pharmacy Calculations for Pharmacy Technicians: Concentrations, Dilutions and Drug Dosing
115390    USP General Chapter <800>: A Pharmacy Professional’s Guide to Handling and Compounding Hazardous Drugs
115388    USP General Chapter <800>: A Pharmacy Professional’s Guide to Handling and Compounding Hazardous Drugs
115124    Pharmacy Calculations for Pharmacy Technicians: Units of Measurement and Methods of Calculation
114850    USP General Chapter <797>: A Guide to Sterile Compounding for Pharmacy Personnel
114849    USP General Chapter <797>: A Guide to Sterile Compounding for Pharmacy Personnel
114338    Keeping up with Supply and Demand: Pharmacy Inventory Management
114157    Aerosol Delivery Devices Used in the Treatment of Asthma: Improving Patient Education to Prevent Hospital Readmissions
114158    Opioid Analgesics: Best Practices for Prescribing, Dispensing, and Preventing Diversion
114117    The Expanding Role of the Pharmacy Technician-MTM and Vaccination Support
114121    Maximizing Patient Interaction at the Pharmacy Counter: OTC Medications for Allergic Rhinitis and the Common Cold
114124    Medication Safety: The Role of the Technician in Preventing Medication Errors
114123    Why Do Drugs Affect People Differently? Understanding Factors That Influence Drug Responses
114125    Appropriate Use of Self-Monitoring Devices: The Pharmacy Technician's Role
114120    Knowing Where to Find Key Drug Information-Understanding Drug Resources
114111    Common Childhood Illnesses: Considerations for the Pharmacy Technician
113830    Pharmacotherapeutic Agents for Smoking Cessation
113790    Module 4. Blood Glucose Monitoring
113785    Module 1: Diabetes Defined: Pathophysiology
113768    Module 9: Providing Pharmaceutical Care and Products for Horses
113764    Module 8: Providing Pharmaceutical Care and Products for Cats
113762    Module 7: Providing Pharmaceutical Care and Products for Dogs
113745    Module 6: Top 25 Veterinary-Only Prescription Drugs
Part 2: Hormonal Drugs and Selected Individual Agents

113744    Module 5: Top 25 Veterinary-Only Prescription Drugs
Part 1: Antimicrobial Agents and Nonsteroidal Anti-Inflammatory Drugs

113738    Module 4: Veterinary Drug Information Resources
113693    Module 3: Regulatory and Ethical Issues in Veterinary Pharmacy
113720    Module 2: Principles of Toxicology in Non-Human Species